Incidence Rates Table
County
|
Age-Adjusted Incidence Rate† cases per 100,000 (95% Confidence Interval) 
|
CI*Rank⋔ (95% Confidence Interval)
|
Average Annual Count
|
Recent Trend |
Recent 5-Year Trend‡ in Incidence Rates (95% Confidence Interval)
|
|---|---|---|---|---|---|
| Massachusetts 7 | 461.3 (459.0, 463.7) | N/A | 32,936 |
stable 
|
-0.2 (-0.8, 0.9) |
| US (SEER+NPCR)ยง 1 | 461.9 (461.6, 462.3) | N/A | 1,273,624 |
stable
|
-0.2 (-0.5, 0.2) |
| Middlesex County 7 | 440.9 (436.1, 445.7) | 12 (9, 12) | 6,978 |
falling 
|
-1.4 (-4.1, -1.1) |
| Worcester County 7 | 477.7 (471.0, 484.5) | 3 (2, 8) | 4,248 |
stable
|
0.0 (-0.2, 0.1) |
| Essex County 7 | 470.9 (464.0, 477.9) | 6 (3, 9) | 3,973 |
stable
|
-0.2 (-1.2, 1.4) |
| Norfolk County 7 | 475.4 (468.1, 482.7) | 5 (2, 8) | 3,590 |
stable
|
-0.5 (-0.9, 0.4) |
| Bristol County 7 | 470.9 (463.2, 478.6) | 7 (3, 9) | 3,122 |
falling
|
-0.5 (-0.9, -0.1) |
| Plymouth County 7 | 482.8 (474.8, 490.9) | 2 (1, 6) | 3,027 |
falling
|
-0.9 (-1.4, -0.4) |
| Hampden County 7 | 447.4 (438.2, 456.8) | 10 (8, 12) | 2,038 |
stable
|
1.4 (-0.7, 2.7) |
| Barnstable County 7 | 477.2 (466.0, 488.6) | 4 (2, 9) | 1,878 |
falling
|
-1.1 (-1.4, -0.8) |
| Suffolk County 7 | 445.7 (436.2, 455.3) | 11 (9, 12) | 1,811 |
stable
|
-1.5 (-2.1, 0.1) |
| Berkshire County 7 | 465.4 (450.7, 480.6) | 8 (2, 10) | 893 |
stable
|
0.7 (0.0, 1.9) |
| Hampshire County 7 | 409.9 (396.1, 424.1) | 14 (13, 14) | 756 |
falling
|
-1.2 (-1.6, -0.8) |
| Franklin County 7 | 416.7 (398.1, 436.1) | 13 (12, 14) | 437 |
falling
|
-0.8 (-1.3, -0.2) |
| Dukes County 7 | 459.1 (420.6, 500.8) | 9 (1, 13) | 123 |
stable
|
-1.0 (-2.1, 0.2) |
| Nantucket County 7 | 543.0 (482.3, 609.9) | 1 (1, 8) | 63 |
stable
|
-0.8 (-2.6, 0.9) |
Notes:
Created by statecancerprofiles.cancer.gov on 04/30/2024 8:37 am.
State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.
Created by statecancerprofiles.cancer.gov on 04/30/2024 8:37 am.
State Cancer Registries may provide more current or more local data.
† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.
^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.
Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.